Amirabbas Nikkhah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amirabbas Nikkhah has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Rezazadeh- Mafi
Department of Radiation Oncology, Imam Hossein Hospital, Shaheed Beheshti Medical University, Tehran, Iran
3 shared publications - Akram Tayanloo-Beik
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Babak Arjmand
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Bagher Larijani
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Mostafa Rezaei-Tavirani
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications - Fatemeh Fazeli Shouroki
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 5 August 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-12
Prevalence, awareness, treatment, and control of prediabetes and diabetes mellitus in older adults: findings from Iranian STEPS surveys (2016 and 2021)
Diabetes mellitus (DM) is a significant public health concern, particularly among older adults who face an elevated risk of complications and increased mortality. This study assessed overtime changes in the prevalence, awareness, treatment coverage, and glycemic control of DM in Iranian adults aged 60 and older. This is a nationwide repeated cross-sectional study based on data from the 2016 and 2021 STEPwise Approach to Non-communicable Disease Risk Factor Surveillance (STEPS), the most recent surveys conducted across all provinces of Iran. We reported prevalence estimates as weighted percentages with 95% confidence intervals (CIs). Logistic regression was used to evaluate the association between selected demographic and health characteristics and diabetes mellitus (DM). All analyses were performed using R statistical software version 4.0.5. From 2016 to 2021, the prevalence of prediabetes increased from 23.86 to 28.96% in males and from 22.86 to 30.86% in females, while DM prevalence rose from 19.37 to 25.43% in males and from 26.22 to 30.26% in females. In 2016, DM awareness was 74.47% in males and 82.19% in females, and in 2021, it was 71.20% in males and 78.73% in females. Treatment coverage was 60.18% in males and 67.63% in females in 2016, and 63.71% in males and 71.14% in females in 2021. Glycemic control was 59.77% in males and 57.98% in females in 2016, and 55.96% in males and 53.66% in females in 2021. Obesity significantly increased the odds of DM (odds ratio (OR) 1.97, p < 0.001), while being underweight (OR 0.21, p < 0.001) and having sufficient physical activity (OR 0.77, p = 0.02) were protective factors. The findings from the 2016 and 2021 STEPS surveys indicate a rising burden of prediabetes and DM among older adults in Iran, particularly among females. Although awareness and treatment coverage were high, optimal glycemic control remains a challenge, emphasizing the need to improve access to healthcare resources and develop tailored community-based interventions.
- 5 August 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-12
Open AccessPrevalence, awareness, treatment, and control of prediabetes and diabetes mellitus in older adults: findings from Iranian STEPS surveys (2016 and 2021)
Diabetes mellitus (DM) is a significant public health concern, particularly among older adults who face an elevated risk of complications and increased mortality. This study assessed overtime changes in the prevalence, awareness, treatment coverage, and glycemic control of DM in Iranian adults aged 60 and older. This is a nationwide repeated cross-sectional study based on data from the 2016 and 2021 STEPwise Approach to Non-communicable Disease Risk Factor Surveillance (STEPS), the most recent surveys conducted across all provinces of Iran. We reported prevalence estimates as weighted percentages with 95% confidence intervals (CIs). Logistic regression was used to evaluate the association between selected demographic and health characteristics and diabetes mellitus (DM). All analyses were performed using R statistical software version 4.0.5. From 2016 to 2021, the prevalence of prediabetes increased from 23.86 to 28.96% in males and from 22.86 to 30.86% in females, while DM prevalence rose from 19.37 to 25.43% in males and from 26.22 to 30.26% in females. In 2016, DM awareness was 74.47% in males and 82.19% in females, and in 2021, it was 71.20% in males and 78.73% in females. Treatment coverage was 60.18% in males and 67.63% in females in 2016, and 63.71% in males and 71.14% in females in 2021. Glycemic control was 59.77% in males and 57.98% in females in 2016, and 55.96% in males and 53.66% in females in 2021. Obesity significantly increased the odds of DM (odds ratio (OR) 1.97, p < 0.001), while being underweight (OR 0.21, p < 0.001) and having sufficient physical activity (OR 0.77, p = 0.02) were protective factors. The findings from the 2016 and 2021 STEPS surveys indicate a rising burden of prediabetes and DM among older adults in Iran, particularly among females. Although awareness and treatment coverage were high, optimal glycemic control remains a challenge, emphasizing the need to improve access to healthcare resources and develop tailored community-based interventions.
- 15 April 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (6) , 1250-1259
Analysis of Associated Abnormalities and Outcome Assessment in Malformations of the Corpus Callosum Diagnosed via Fetal MRI: A Cross‐Sectional Study
Background: The study explores corpus callosum malformation (CCM) using comprehensive brain Magnetic Resonance Imaging (MRI) for the assessment of associated malformations and their relation to long‐term outcomes.Methods: During a 7‐year period, all cases of CCM diagnosed via fetal MRI were retrospectively studied. Neurodevelopmental outcomes were assessed through postnatal interviews. Fetal brain imaging was performed using a 1.5‐T MRI scanner without sedation, focusing on CC development and associated anomalies.Results: The study included 59 participants with CCM. Isolated CCM was observed in 25.4% of cases, while 74.6% presented with additional intracranial abnormalities, including cortical malformation (45.8%), periventricular nodular heterotopia (25.4%), supratentorial parenchymal signal intensity abnormality (25.4%), and sulcation delay (16.9%). Additionally, 16.9% of CCM cases were associated with non‐neurological anomalies, such as craniofacial malformations (8.5%) and urinary abnormalities (5.1%). In terms of pregnancy outcomes, 20.3% underwent pregnancy termination, 5.1% ended in stillbirth, 22.0% resulted in death after birth, and 52.5% resulted in live births. A significant association was observed between the coexistence of cortical malformation and poor prognosis (p = 0. 012).Conclusion: The broad spectrum of anomalies linked to CCM, along with their clinical outcomes, underscores the pivotal role of MRI in prenatal screening for fetuses diagnosed with CCM.
- 15 April 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (6) , 1250-1259
Analysis of Associated Abnormalities and Outcome Assessment in Malformations of the Corpus Callosum Diagnosed via Fetal MRI: A Cross‐Sectional Study
Background: The study explores corpus callosum malformation (CCM) using comprehensive brain Magnetic Resonance Imaging (MRI) for the assessment of associated malformations and their relation to long‐term outcomes.Methods: During a 7‐year period, all cases of CCM diagnosed via fetal MRI were retrospectively studied. Neurodevelopmental outcomes were assessed through postnatal interviews. Fetal brain imaging was performed using a 1.5‐T MRI scanner without sedation, focusing on CC development and associated anomalies.Results: The study included 59 participants with CCM. Isolated CCM was observed in 25.4% of cases, while 74.6% presented with additional intracranial abnormalities, including cortical malformation (45.8%), periventricular nodular heterotopia (25.4%), supratentorial parenchymal signal intensity abnormality (25.4%), and sulcation delay (16.9%). Additionally, 16.9% of CCM cases were associated with non‐neurological anomalies, such as craniofacial malformations (8.5%) and urinary abnormalities (5.1%). In terms of pregnancy outcomes, 20.3% underwent pregnancy termination, 5.1% ended in stillbirth, 22.0% resulted in death after birth, and 52.5% resulted in live births. A significant association was observed between the coexistence of cortical malformation and poor prognosis (p = 0. 012).Conclusion: The broad spectrum of anomalies linked to CCM, along with their clinical outcomes, underscores the pivotal role of MRI in prenatal screening for fetuses diagnosed with CCM.
- 12 April 2025
- Published by Elsevier in Geriatric Nursing
- Vol. 63, 280-287
Handgrip strength and gait speed relationships with cognitive impairment in Iranian older adults: Birjand longitudinal aging study
- 12 April 2025
- Published by Elsevier in Geriatric Nursing
- Vol. 63, 280-287
Handgrip strength and gait speed relationships with cognitive impairment in Iranian older adults: Birjand longitudinal aging study
- 4 November 2023
- Published by Springer Nature
- p. 165-188
DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game
Stem cells, as a group of undifferentiated cells, are enriched with self-renewal and high proliferative capacity, which have attracted the attention of many researchers as a promising approach in the treatment of many diseases over the past years. However, from the cellular and molecular point of view, the DNA repair system is one of the biggest challenges in achieving therapeutic goals through stem cell technology. DNA repair mechanisms are an advantage for stem cells that are constantly multiplying to deal with various types of DNA damage. However, this mechanism can be considered a trump card in the game of cell survival and treatment resistance in cancer stem cells, which can hinder the curability of various types of cancer. Therefore, getting a deep insight into the DNA repair system can bring researchers one step closer to achieving major therapeutic goals. The remarkable thing about the DNA repair system is that this system is not only under the control of genetic factors, but also under the control of epigenetic factors. Therefore, it is necessary to investigate the role of the DNA repair system in maintaining the survival of cancer stem cells from both aspects. Keywords Cancer stem cell DNA damage response DNA mismatch repair DNA repair Stem cells
- 4 November 2023
- Published by Springer Nature
- p. 165-188
DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game
Stem cells, as a group of undifferentiated cells, are enriched with self-renewal and high proliferative capacity, which have attracted the attention of many researchers as a promising approach in the treatment of many diseases over the past years. However, from the cellular and molecular point of view, the DNA repair system is one of the biggest challenges in achieving therapeutic goals through stem cell technology. DNA repair mechanisms are an advantage for stem cells that are constantly multiplying to deal with various types of DNA damage. However, this mechanism can be considered a trump card in the game of cell survival and treatment resistance in cancer stem cells, which can hinder the curability of various types of cancer. Therefore, getting a deep insight into the DNA repair system can bring researchers one step closer to achieving major therapeutic goals. The remarkable thing about the DNA repair system is that this system is not only under the control of genetic factors, but also under the control of epigenetic factors. Therefore, it is necessary to investigate the role of the DNA repair system in maintaining the survival of cancer stem cells from both aspects. Keywords Cancer stem cell DNA damage response DNA mismatch repair DNA repair Stem cells
- 2 November 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (1) , 91-107
Brown adipose tissue and alzheimer’s disease
Alzheimer’s disease (AD), the most common type of senile dementia, is a chronic neurodegenerative disease characterized by cognitive dysfunction and behavioral disability. The two histopathological hallmarks in this disease are the extraneuronal accumulation of amyloid-β (Aβ) and the intraneuronal deposition of neurofibrillary tangles (NFTs). Despite this, central and peripheral metabolic dysfunction, such as abnormal brain signaling, insulin resistance, inflammation, and impaired glucose utilization, have been indicated to be correlated with AD. There is solid evidence that the age-associated thermoregulatory deficit induces diverse metabolic changes associated with AD development. Brown adipose tissue (BAT) has been known as a thermoregulatory organ particularly vital during infancy. However, in recent years, BAT has been accepted as an endocrine organ, being involved in various functions that prevent AD, such as regulating energy metabolism, secreting hormones, improving insulin sensitivity, and increasing glucose utilization in adult humans. This review focuses on the mechanisms of BAT activation and the effect of aging on BAT production and signaling. Specifically, the evidence demonstrating the effect of BAT on pathological mechanisms influencing the development of AD, including insulin pathway, thermoregulation, and other hormonal pathways, are reviewed in this article.
- 2 November 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (1) , 91-107
Brown adipose tissue and alzheimer’s disease
Alzheimer’s disease (AD), the most common type of senile dementia, is a chronic neurodegenerative disease characterized by cognitive dysfunction and behavioral disability. The two histopathological hallmarks in this disease are the extraneuronal accumulation of amyloid-β (Aβ) and the intraneuronal deposition of neurofibrillary tangles (NFTs). Despite this, central and peripheral metabolic dysfunction, such as abnormal brain signaling, insulin resistance, inflammation, and impaired glucose utilization, have been indicated to be correlated with AD. There is solid evidence that the age-associated thermoregulatory deficit induces diverse metabolic changes associated with AD development. Brown adipose tissue (BAT) has been known as a thermoregulatory organ particularly vital during infancy. However, in recent years, BAT has been accepted as an endocrine organ, being involved in various functions that prevent AD, such as regulating energy metabolism, secreting hormones, improving insulin sensitivity, and increasing glucose utilization in adult humans. This review focuses on the mechanisms of BAT activation and the effect of aging on BAT production and signaling. Specifically, the evidence demonstrating the effect of BAT on pathological mechanisms influencing the development of AD, including insulin pathway, thermoregulation, and other hormonal pathways, are reviewed in this article.
- 25 August 2022
- Published by Springer Nature
- Vol. 1409, 83-110
Application of Biocompatible Scaffolds in Stem-Cell-Based Dental Tissue Engineering
Tissue engineering as an important field in regenerative medicine is a promising therapeutic approach to replace or regenerate injured tissues. It consists of three vital steps including the selection of suitable cells, formation of 3d scaffolds, and adding growth factors. Mesenchymal stem cells (MSCs) and embryonic stem cells (ESCs) are mentioned as two main sources for this approach that have been used for the treatment of various types of disorders. However, the main focus of literature in the field of dental tissue engineering is on utilizing MSCs. On the other hand, biocompatible scaffolds play a notable role in this regenerative process which is mentioned to be harmless with acceptable osteoinductivity. Their ability in inhibiting inflammatory responses also makes them powerful tools. Indeed, stem cell functions should be supported by biomaterials acting as scaffolds incorporated with biological signals. Naturally derived polymeric scaffolds and synthetically engineered polymeric/ceramic scaffolds are two main types of scaffolds regarding their materials that are defined further in this review. Various strategies of tissue bioengineering can affect the regeneration of dentin-pulp complex, periodontium regeneration, and whole teeth bioengineering. In this regard, in vivo/ex vivo experimental models have been developed recently in order to perform preclinical studies of dental tissue engineering which make it more transferable to be used for clinic uses. This review summarizes dental tissue engineering through its different components. Also, strategies of tissue bioengineering and experimental models are introduced in order to provide a perspective of the potential roles of dental tissue engineering to be used for clinical aims. Keywords Dentistry Embryonic Mesenchymal stem cells Regenerative medicine Stem cells Tissue scaffolds
- 25 August 2022
- Published by Springer Nature
- Vol. 1409, 83-110
Application of Biocompatible Scaffolds in Stem-Cell-Based Dental Tissue Engineering
Tissue engineering as an important field in regenerative medicine is a promising therapeutic approach to replace or regenerate injured tissues. It consists of three vital steps including the selection of suitable cells, formation of 3d scaffolds, and adding growth factors. Mesenchymal stem cells (MSCs) and embryonic stem cells (ESCs) are mentioned as two main sources for this approach that have been used for the treatment of various types of disorders. However, the main focus of literature in the field of dental tissue engineering is on utilizing MSCs. On the other hand, biocompatible scaffolds play a notable role in this regenerative process which is mentioned to be harmless with acceptable osteoinductivity. Their ability in inhibiting inflammatory responses also makes them powerful tools. Indeed, stem cell functions should be supported by biomaterials acting as scaffolds incorporated with biological signals. Naturally derived polymeric scaffolds and synthetically engineered polymeric/ceramic scaffolds are two main types of scaffolds regarding their materials that are defined further in this review. Various strategies of tissue bioengineering can affect the regeneration of dentin-pulp complex, periodontium regeneration, and whole teeth bioengineering. In this regard, in vivo/ex vivo experimental models have been developed recently in order to perform preclinical studies of dental tissue engineering which make it more transferable to be used for clinic uses. This review summarizes dental tissue engineering through its different components. Also, strategies of tissue bioengineering and experimental models are introduced in order to provide a perspective of the potential roles of dental tissue engineering to be used for clinical aims. Keywords Dentistry Embryonic Mesenchymal stem cells Regenerative medicine Stem cells Tissue scaffolds